ViiV Healthcare’s Tivicay PD Wins FDA Approval for Kids
LONDON, Aug 26, 2026 The U.S. Food and Drug Administration (FDA) has approved Tivicay PD (dolutegravir) from ViiV Healthcare...
Dolutegravir
Advertisement
HighLife Wins CE Mark for Next-Gen Clarity Valve
PARIS, FRANCE, Aug 27, 2026 HighLife SAS, a medical technology company developing transcatheter mitral valve replacement solutions, has received...
IceCure Launches ChoICE Study for ProSense in U.S.
Caesarea, Israel, July 27, 2026 IceCure Medical Ltd. has announced the launch of its post-marketing ChoICE Study, with the...
ViiV Healthcare Reports Positive Phase IIIb Dovato Results
London, July 27, 2026 ViiV Healthcare has announced positive Week 48 results from the Phase IIIb VOGUE study, demonstrating...
Advertisement
